Veeva Systems Inc

VEEV

Equity

ISIN null / Valor 22346723

New York Stock Exchange, Inc (2026-02-27)

USD 182.01-0.46%

Veeva Systems Inc
UMushroom community rating:

5.00 2 votes No rating yet

NegativeNeutralPositive

About company

Veeva Systems Inc is a leading provider of cloud-based software solutions for the life sciences industry, offering services in customer relationship management, customer master data, and marketing. The company's executive team, including individuals like Adriano Vieira, Pinal, Erik Smith, Nitsa Zuppas, Tom Schwenger, and Peter Gassner, bring decades of experience in the industry and play key roles in driving the company's global operations, IT organization, R&D and Quality sales, customer success, and overall company direction. Veeva's focus on providing innovative solutions and exceptional customer service has solidified its position as an industry leader in the field of enterprise software for life sciences companies.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-17.6%1Y

9.81%3Y

-35.0%5Y

Performance

34.3%1Y

33.8%3Y

37.5%5Y

Volatility

29919 M

Market cap (USD)

2,562,198

Daily traded volume (Shares)

212.58 / 209.5

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

2 votes

Performance:

4.50

Innovation:

5.00

Society:

4.00

Nature:

5.00

Mercedes Neuhaus

Switzerland, 15 Apr 2025

Veeva System hat ein solides Wachstum bei den Abonnenten. Expansion in neue Märkte. Wachstum beim Free Cashflow. Solide Akte für langfristig orientierte Investoren

Mercedes Neuhaus

Switzerland, 24 Mar 2025

Veeva System ist ein führender Anbieter von Cloud-Software für die Life-Sciences-Branche. Mit Lösung für CRM, Daten- und Qualitätsmanagement unterstützt es Pharma- und Biotechunternehmen effizient. Starke Innovation. Finanzstabilität bleibt hoch. Konkurrenzdruck wächst.

EQUITIES OF THE SAME SECTOR

DXC Technology Company